Shi-hui Ren
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Mesenchymal stem cells in intrahepatic and extrahepatic biliary diseases: mechanisms and therapeutic applications.
Journal: Frontiers in cell and developmental biology
Published: April 22, 2026
Efficacy and safety of BCMA-directed CAR T-cell therapy in extramedullary relapsed or refractory multiple myeloma: a meta-analysis.
Journal: Frontiers in immunology
Published: January 21, 2026
Zanubrutinib enhances CD19 CAR T killing of B-cell lymphoma by inhibiting BTK phosphorylation, regulating PI3K/AKT/mTOR pathway, and promoting autophagy.
Journal: Blood science (Baltimore, Md.)
Published: September 23, 2025
Correction: BCMA/GPRC5D bispecific CAR T-cell therapy for relapsed/refractory multiple myeloma with extramedullary disease: a single-center, single-arm, phase 1 trial.
Journal: Journal of hematology & oncology
Published: June 03, 2025
CAR T-cells vs. bispecific antibodies as third- or later-line treatment for relapsed/refractory follicular lymphoma: a literature review and meta-analysis.
Journal: Frontiers in immunology
Published: April 15, 2025
BCMA/GPRC5D bispecific CAR T-cell therapy for relapsed/refractory multiple myeloma with extramedullary disease: a single-center, single-arm, phase 1 trial.
Journal: Journal of hematology & oncology
Published: April 01, 2025
Rapid development of acute monocytic leukemia (AML-M5b) with t(9;11)(p22;q23) after chemotherapy for T-cell lymphoblastic lymphoma: A case report.
Journal: Heliyon
Published: March 03, 2024
Role of the bone marrow microenvironment in multiple myeloma treatment using CAR-T therapy.
Journal: Expert review of anticancer therapy
Published: June 21, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026